Cognitive effects of atypical antipsychotic drugs in first-episode drug-naïve schizophrenic patients

Neural Regeneration Research

Volumn 8, Issue 3, 2013, Pages 277-286

  Wang, Juan ^a   Hu, Mao Rong ^a   Guo, Xiao Feng ^a   Wu, Ren Rong ^a   Li, Le Hua ^a   Zhao, Jing Ping ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Aripiprazole; Clinical practice; Cognition; Grant supported paper; Memory; Neural regeneration; Neuroregeneration; Olanzapine; Risperidone; Schizophrenia

Indexed keywords

ALPRAZOLAM; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; OLANZAPINE; RISPERIDONE; TRIHEXYPHENIDYL;

ADOLESCENT; ADULT; AGITATION; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG EFFECT; DRUG EFFICACY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; FOLLOW UP; HOPKINS VERBAL LEARNING TEST; HUMAN; INSOMNIA; KRUSKAL WALLIS TEST; LEARNING; LEARNING TEST; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL DISEASE ASSESSMENT; OPEN STUDY; OUTCOME ASSESSMENT; POSITIVE AND NEGATIVE SYNDROME SCALE; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SPATIAL MEMORY TEST; VERBAL MEMORY; VISUOSPATIAL MEMORY TEST;

EID: 84925595130     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.3969/j.issn.1673-5374.2013.03.011     Document Type: Article

References (39)

1. Nuechterlein KH, Barch DM, Gold JM, et al. Identification of separable cognitive factors in schizophrenia. Schizophr Res. 2004;72(1):29-39.
2. Keefe RS, Seidman LJ, Christensen BK, et al. Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol. Am J Psychiatry. 2004; 161(6):985-995.
3. Hill SK, Bishop JR, Palumbo D, et al. Effect of secondgeneration antipsychotics on cognition: current issues and future challenges. Expert Rev Neurother. 2010;10(1):43-57.
4. Crespo-Facorro B, Rodriguez-Sanchez JM, Perez-Iglesias R, et al. Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison. J Clin Psychiatry. 2009;70(5):717-729.
5. Andersen R, Fagerlund B, Rasmussen H et al. Cognitive effects of six months of treatment with quetiapine in antipsychotic-naive first-episode schizophrenia. Psychiatry Res. 2011;187(1-2):49-54.
6. Davidson M, Galderisi S, Weiser M, et al. Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST). Am J Psychiatry. 2009;166(6): 675-682.
7. Woodward ND, Purdon SE, Meltzer HY, et al. A meta-analysis of cognitive change with haloperidol in clinical trials of atypical antipsychotics: dose effects and comparison to practice effects. Schizophr Res. 2007; 89(1-3):211-224.
8. Woodward ND, Purdon SE, Meltzer HY, et al. A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. Int J Neuropsychopharmacol. 2005;8(3):457-472.
9. Cuesta MJ, Jalon EG, Campos MS, et al. Cognitive effectiveness of olanzapine and risperidone in firstepisode psychosis. Br J Psychiatry. 2009;194(5): 439-445.
10. Riedel M, Schennach-Wolff R, Musil R, et al. Neurocognition and its influencing factors in the treatment of schizophrenia-effects of aripiprazole, olanzapine, quetiapine and risperidone. Hum Psychopharmacol. 2010; 25(2):116-125.
11. Robles O, Zabala A, Bombin I, et al. Cognitive efficacy of quetiapine and olanzapine in early-onset first-episode psychosis. Schizophrenia Bull. 2011;37(2):405-415.
12. Keefe RSE, Sweeney JA, Gu H, et al. Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison. Am J Psychiat. 2007;164(7):1061-1071.
13. Crespo-Facorro B, Rodriguez-Sanchez JM, Perez-Iglesias R, et al. Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison. J Clin Psychiatry. 2009;70(5):717-729.
14. Guo X, Zhai J, Wei Q, et al. Neurocognitive effects of firstand second-generation antipsychotic drugs in early-stage schizophrenia: a naturalistic 12-month follow-up study. Neurosci Lett. 2011;503(2):141-146.
15. Klasik A, Krysta K, Krzystanek M, et al. Impact of olanzapine on cognitive functions in patients with schizophrenia during an observation period of six months. Psychiatr Danub. 2011;23(Suppl 1):S83-86.
16. Mucci A, Piegari G, Galderisi S,et al. Cognitive-enhancing effects of aripiprazole: a case report. Clin Pract Epidemiol Ment Health. 2008;4:24.
17. Hori H, Yoshimura R, Katsuki A, et al. The cognitive profile of aripiprazole differs from that of other atypical antipsychotics in schizophrenia patients. J Psychiatr Res. 2012;46(6):757-761.
18. Yasui-Furukori N, Kaneda A, Sugawara N, et al. Effect of adjunctive treatment with aripiprazole to atypical antipsychotics on cognitive function in schizophrenia patients. J Psychopharmacol. 2012;26(6):806-812.
19. Meltzer HY, McGurk SR. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophr Bull. 1999;25(2):233-255.
20. Keefe RS, Seidman LJ, Christensen BK et al. Long-term neurocognitive effects of olanzapine or low-dose haloperidol in first-episode psychosis. Biol Psychiatry. 2006;59(2):97-105.
21. Harvey PD, Rabinowitz J, Eerdekens M, et al. Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial. Am J Psychiatry. 2005;162(10):1888-1895.
22. Malla A, Norman R, Scholten D, et al. A comparison of two novel antipsychotics in first episode non-affective psychosis: one-year outcome on symptoms, motor side effects and cognition. Psychiat Res. 2004;129(2): 159-169.
23. Riedel M, Spellmann I, Schennach-Wolff R, et al. Effect of aripiprazole on cognition in the treatment of patients with schizophrenia. Pharmacopsychiatry. 2010;43(2):50-57.
24. Keefe RSE, Young CA, Rock SL, et al. One-year double-blind study of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in schizophrenia. Schizophr Res. 2006;81(1):1-15.
25. Purdon SE, Jones BD, Stip E, et al. Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia. Arch Gen Psychiatry. 2000;57(3):249-258.
26. Keefe RSE, Bilder RM, Davis SM, et al. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial. Arch Gen Psychiat. 2007;64(6):633-647.
27. Keefe RSE, Silva SG, Perkins DO, et al. The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis. Schizophr Bull. 1999;25(2):201-222.
28. Li Z, Ichikawa J, Dai J, Meltzer HY. Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain. Eur J Pharmacol. 2004;493(1-3):75-83.
29. Harvey PD, Koren D, Reichenberg A, et al. Negative symptoms and cognitive deficits: what is the nature of their relationship? Schizophr Bull. 2006;32(2):250-258.
30. Gold JM. Cognitive deficits as treatment targets in schizophrenia. Schizophr Res. 2004;72(1):21-28.
31. Goldberg TE, Goldman RS, Burdick KE, et al. Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect? Arch Gen Psychiatry. 2007;64(10): 1115-1122.
32. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261-276.
33. State Council of the People's Republic of China. Administrative Regulations on Medical Institution. 1994-09-01.
34. Brandt J, Benedict RH. Hopkins Verbal Learning Test- Revised. Lutz, FL: Psychological Assessment Resources, Inc. 2001.
35. Benedict RH. Brief Visuospatial Memory Test-Revised: Professional Manual. Odessa, Fla: Psychological Assessment Resources, Inc. 1997.
36. rd ed. San Antonio, Tex: Psychological Corp. 1997.
37. Benton AL, Hamsher K. Multilingual Aphasia Examination Manual (revised). University of Iowa: Lowa City, IA. 1978.
38. Golden C. Stroop Color and Word Test: A Manual for Clinical Experimental Uses. Wood Dale, Ill, Stoelting Co. 1978.
39. Cohen J. Statistical power analysis for the behavioral sciences. Mahwah, NJ: Lawrence Erlbaum Associates. 1988.